Intrommune Therapeutics Appoints Sergi Trilla, MD, MBA to its Scientific and Business Advisory Boards Press Releases / By Intrommune
Drug Development & Delivery: Oral Mucosal Delivery of Allergenic Proteins for Inducing Tolerance in Food Allergic Individuals In the News / By Intrommune
Intrommune Therapeutics selected as a “Winning Startup” in The Innovate Children’s Health Challenge (ICHC) In the News / By Intrommune
Interesting Engineering: Experimental Toothpaste Might Treat Peanut Allergy In the News / By Intrommune
Research Presentations at the 2021 Annual AAAAI Meeting Highlight Limitations of Current Food Allergy Treatments and Further Validates Intrommune Therapeutics’ Approach Press Releases / By Intrommune
